Study Protocol for a Prospective Longitudinal Cohort Study to Identify Proteomic Predictors of Pluripotent Risk for Mental Illness: The Seoul Pluripotent Risk for Mental Illness Study
- PMID: 32372992
- PMCID: PMC7186772
- DOI: 10.3389/fpsyt.2020.00340
Study Protocol for a Prospective Longitudinal Cohort Study to Identify Proteomic Predictors of Pluripotent Risk for Mental Illness: The Seoul Pluripotent Risk for Mental Illness Study
Abstract
Background: The Seoul Pluripotent Risk for Mental Illness (SPRIM) study was designed to identify predictors leading to mental illness in help-seeking individuals by securing sufficient statistical power through transdiagnostic approaches. The SPRIM study aims to examine the clinical characteristics of high-risk individuals for mental illness and to identify proteomic biomarkers that can predict the onset of mental illness.
Methods: This paper describes the study protocol of the SPRIM study. We aim to recruit 150 participants who meet the criteria for high risk for major mental illness, 150 patients with major psychiatric disorders (schizophrenia, bipolar disorder, and major depressive disorder), and 50 matched healthy control subjects for 2 years. Clinical evaluations, self-report measures, and proteomic analyses will be implemented. The assessment points are at baseline, 6, 12, 18, and 24 months.
Conclusions: In the present study, we introduced the study protocol of the SPRIM study, which is the first prospective cohort study of transdiagnostic high-risk concepts using proteomic biomarkers. This study has a paradigm that encompasses various diseases without aiming at predicting and preventing the development of a specific mental illness in help-seeking individuals. The transdiagnostic high-risk concept could be extended to provide a perspective for people with various psychopathological tendencies below a threshold, such that they do not meet the existing diagnostic criteria of mental illnesses, to determine what may lead them to a specific disease and help identify appropriate preventative interventions.
Keywords: bipolar disorder; high-risk for mental illness; major depressive disorder; pluripotential; proteomics; schizophrenia; transdiagnostic.
Copyright © 2020 Lee, Lee, Lee, Lee, Rhee, Park, Paek, Kim, Kim, Roh, Jung, Kim, Kim, Han, Ahn, Ha and Kwon.
Figures
Similar articles
-
The characteristics and clinical outcomes of a pluripotent high-risk group with the potential to develop a diverse range of psychiatric disorders.J Psychiatr Res. 2024 Jun;174:237-244. doi: 10.1016/j.jpsychires.2024.04.012. Epub 2024 Apr 9. J Psychiatr Res. 2024. PMID: 38653032
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899. Turk Psikiyatri Derg. 2021. PMID: 34964106 English, Turkish.
-
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8. J Clin Psychiatry. 2009. PMID: 19686636 Review.
-
[Predicting bipolar disorder: what can we learn from prospective cohort studies?].Encephale. 2015 Feb;41(1):10-6. doi: 10.1016/j.encep.2013.05.004. Epub 2013 Oct 3. Encephale. 2015. PMID: 24094986 Review. French.
Cited by
-
The Discovery of Clinically Applicable Biomarkers for Bipolar Disorder: A Review of Candidate and Proteomic Approaches.Chonnam Med J. 2020 Sep;56(3):166-179. doi: 10.4068/cmj.2020.56.3.166. Epub 2020 Sep 24. Chonnam Med J. 2020. PMID: 33014755 Free PMC article. Review.
-
Alterations in blood proteins in the prodromal stage of bipolar II disorders.Sci Rep. 2022 Feb 24;12(1):3174. doi: 10.1038/s41598-022-07160-0. Sci Rep. 2022. PMID: 35210508 Free PMC article.
-
Early expressions of psychopathology and risk associated with trans-diagnostic transition to mood and psychotic disorders in adolescents and young adults.PLoS One. 2021 Jun 4;16(6):e0252550. doi: 10.1371/journal.pone.0252550. eCollection 2021. PLoS One. 2021. PMID: 34086749 Free PMC article.
-
Non-psychotic Outcomes in Young People at Ultra-High Risk of Developing a Psychotic Disorder: A Long-Term Follow-up Study.Schizophr Bull. 2024 Nov 8;50(6):1279-1286. doi: 10.1093/schbul/sbae005. Schizophr Bull. 2024. PMID: 38366898 Free PMC article.
References
-
- Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: Results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 67:241–51. 10.1001/archgenpsychiatry.2009.206 - DOI - PubMed
-
- Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, et al. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry: Off J World Psychiatr Assoc (WPA) (2015) 14:322–32. 10.1002/wps.20250 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources